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As for all retroviruses, the env mRNA is thought to be a singly spliced product of the full-length transcript from the P1 promoter in the
MMTV provirus. However, we show that envelope proteins can be produced in an inducible manner in the absence of the P1 promoter from
an otherwise complete provirus. Furthermore, we demonstrate in both reporter assays and the proviral context that the R region is necessary
for protein production in transiently transfected cells and in a number of independent, stably transfected cell clones. Using 5VRACE, we show
that a sequence within the R region functions as a TATA less initiator. The most distal part of the 5V LTR (first 804 bases of the U3 region) is
required for the activity of the R-initiator element only when the provirus is integrated. Transfection with a full-length proviral DNA carrying
a deletion of P1 in the 5V LTR resulted in the establishment of stable cell clones able to produce Env in a dexamethasone-dependent manner
but not infectious virions. We therefore conclude that in the absence of P1, R can drive transcription of the spliced env mRNA but not
genomic viral RNA.
D 2005 Elsevier Inc. All rights reserved.Keywords: MMTV; LTR promoters; Env expression; Initiator element; Differential transcriptional regulationIntroduction
The major P1 promoter carried by the LTR of mouse
mammary tumor virus (MMTV) has been extensively
studied since it has been revealed that its activity is
dependent of host steroid hormone status (Fasel et al.,
1982; Scheidereit et al., 1983; Buetti and Diggelmann,
1983; Hynes et al., 1983; Majors and Varmus, 1983). Other
transcription factors have also been implicated in the control
of the P1 promoter, such as nuclear factor 1 (NF-1)
(Nowock et al., 1985; Buetti and Kuhnel, 1986; Cordingley
and Hager, 1988; Cordingley et al., 1987), and octamer
transcription factor 1 (Oct-1) (Meulia and Diggelmann,0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.07.029
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E-mail address: salmons@austrianova.com (B. Salmons).1990; Toohey et al., 1990; Bruggemeier et al., 1991), whose
respective binding sites are situated just upstream of the 19
base pairs encompassing the consensus TATA box of the
LTR P1 promoter core (Kusk et al., 1995). The MMTV LTR
is organized into sequence specifically positioned nucleo-
somes (Richard-Foy and Hager, 1987) and one of these, the
nucleosome B, spans the five hormone responsive elements
and the NF-1 site (Vicent et al., 2002). The role of NF-1 in
MMTV transcription activation is still controversial. The
hormonal activation of the promoter has been proposed to
be a two-step process (Di Croce et al., 1999; Vicent et al.,
2002). In this model, binding of the hormone–receptor
complex results in chromatin remodeling, thus facilitating
NF-1 binding which is required for full occupancy of the
hormone responsive element (HRE) by the hormone–
receptor complex and therefore full activation. In addition
to this chromatin remodeling function of NF-1, Hebbar and05) 201 – 214
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basal transcription in the absence of organized chromatin
(Hebbar and Archer, 2003). As for all other retroviruses, it is
currently assumed that both the Gag-Pol polyprotein tran-
script and the Env Protein transcript are products of the
classic MMTV promoter also known as P1. This promoterFig. 1. Relative luciferase expression from LTR fragments upon transfection of
relevant sequences carried by the reporter construct used for transfection. The bold
TATA box as well as the sequence between the P1 promoter core and the classical
the bold line indicate the site and approximate size of deletion. The dotted box sho
coding sequence. Luciferase expression was determined in the absence (black b
reflects the mean value of at least 3 independent transfections with standard error o
transcription. (B) Effect of R deletion on MMTV LTR transcription. In panels A
Dexamethasone is used as a reference. (C) MMTV genetic elements responsible fo
represent the binding sites for Oct-1 and the gray dot the NF-1 binding site. The H
end of the LTR. Luciferase expression was determined in the absence of dexamet
Each bar reflects the mean value of at least 3 independent transfections with a stand
in the absence of P1 in the LTR fragment is unlikely to be due to the artifactual crea
panel A), nor by a read-through from the bacterial backbone as only borderline
promoterless plasmid pZluc.drives the transcription of a full-length viral mRNA which
has its transcription initiation exactly at the start of the 5V
LTR R (Majors and Varmus, 1983) and ends at the
polyadenylation site at the end of the 3V LTR R region
(Klemenz et al., 1981). Once capped and polyadenylated,
this retroviral primary transcript is able to follow twoCrFK cells. The left part of the figure shows a schematic summary of the
line represents the MMTV sequence, the filled black box represents the P1
site for transcription start and the hatched box the R region. Interruptions in
ws the hormone-responsive element (HRE). The arrow represents luciferase
ars) and in the presence (hatched bars) of dexamethasone (dex). Each bar
f less than 5 % of the mean value. (A) Effect of P1 deletion on MMTV LTR
and B, luciferase expression from pZ1275 when cells were not treated with
r transcription in the absence of P1 TATA box. The two open square boxes
RE is located between bp 995 and bp 1133 relative to the first base of the 5V
hasone. Luciferase expression was normalized to that obtained from pZBN.
ard error of less than 8% of the mean value. The unexpected result obtained
tion of another strong promoter element during the deletion (see sequence in
expression of luciferase is reached after transfection of the cells with the
Fig. 1 (continued).
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exported out of the nucleus without being spliced, to serve
either for translation of Gag and Pol proteins or as genomic
RNA to be packaged into virions, or to be directed to the
spliceosomes before leaving the nucleus for the translation
machinery where it directs Env synthesis (for review, see
Coffin et al., 2001). Although a number of models have
been proposed to account for the observed balance between
spliced and unspliced retroviral RNAs (Fu et al., 1991),
exactly how the fate of the full-length mRNA in the nucleus
of the host cell is controlled is still unknown.
MMTV Env glycoproteins are encoded by a subgenomic
mRNA which is derived as a single spliced product of the
genomic length RNA (Redmond and Dickson, 1983;
Henderson et al., 1983; Majors and Varmus, 1983).
Glucocorticoids regulate the transport and processing of
MMTV glycoproteins in virus-infected cells (Rabindran et
al., 1987; Corey and Stallcup, 1990) and increase the
stability of MMTV glycoproteins by a posttranscriptional
mechanism without affecting the level of env transcripts
(Goodman and Firestone, 1993).
An initiator-like promoter element (Inr) has been
identified downstream of the initiation site of the P1
promoter, inside the R region, which is specifically
recognized by a host-encoded nuclear protein, termed
initiation site binding protein (ISBP) (Pierce et al., 1993;
Fee et al., 2002). Its presence is thought to be required for
optimal levels of LTR promoter activity (Pierce et al., 1993)
and spacing between the TATA box of P1 and the ISBP site
is important for P1 promoter function (Fee et al., 2002).
Although initiator elements are known to be able to promote
initiation in the absence of a TATA box, this could yet not be
demonstrated for the MMTV ISBP (Fee et al., 2002).Besides the major P1 LTR promoter, which is common to
all retroviruses, another promoter (P2) has been reported in
the central part of the U3 region (Gunzburg et al., 1993;
Wintersperger et al., 1995). During the characterization of
the P2 promoter, using a promoterless luciferase reporter
system, we observed high levels of luciferase expression
from an LTR bearing a 38-bp deletion of the P1 promoter
core, including the P1 TATA box and ending at the
transcription start. Further studies demonstrated that an
MMTV provirus deleted only in the P1 promoter core is still
able to produce Env in a hormone-dependent way, as
efficiently as a non-deleted provirus. We show here that the
MMTV R region is required and sufficient for both
luciferase expression in the reporter system and Env
expression in the viral genomic context in the absence of
the P1 promoter core.Results and discussion
Basal MMTV LTR transcriptional activity is not abolished
by the P1 promoter core deletion but is dramatically
increased
Using a promoterless luciferase reporter system, we
analyzed the effect of short deletions that do not disturb
the nucleosome B structure on the overall transcriptional
activity of the MMTV LTR. The plasmids pZ1303 and
pZ1316 carry wild type Mtv-2 LTR sequences from the
first base of the U3 region to +109 relative to the
transcriptional start from P1. The only difference between
the two constructs is a 5-bp insertion just upstream of the
R region. Fig. 1 shows that this short insertion (pZ1316)
S. Rungaldier et al. / Virology 342 (2005) 201–214204has no effect on either the regulation of the promoter by
dexamethasone, or the level of transcription (Fig. 1A,
pZ1303 compared to pZ1316). However, the deletion of a
38-bp region including the P1 TATA box and the
sequence between the core region of this promoter and
R (pZ1275) leads to a dramatic and unexpected upregu-
lation of transcription in the absence of dexamethasone
(Fig. 1A, pZ1275 compared to pZ1316). Transcriptional
activity is even slightly increased in the presence of
dexamethasone.
The first 804 bp of the U3 region are not required for
transcriptional activity in the absence of P1
The search for the LTR element which is responsible for
this strong transcriptional effect in the absence of the P1
promoter first focused on the second promoter (P2) located
in the central part of the MMTV LTR (Gunzburg et al.,
1993). However, a deletion of the first 804 bp of the LTR,
including the P2 promoter and its cap site (pZBN), did not
affect the observed luciferase activity (Fig. 1A, pZBN
compared to pZ1275) after transient transfection, thus ruling
out the involvement of P2.
The sequence CAACAGTCCTAA of the R region is essential
for transcriptional activity in the absence of P1
An initiator (Inr) that effects the position of the tran-
scriptional start, but is not competent to allow transcription
on its own, has been reported to be contained in the R region
of the 5V LTR (Pierce et al., 1993). Therefore, we deleted
12 bp in the R region that encompasses this element
(pZ1275DR). Transient transfections of this construct results
in abolishment of transcriptional activity both in the presence
and absence of dexamethasone (Fig. 1B, compare pZ1275
with pZ1275DR).
The R-initiator requires U3 sequences between 804 and
1155 for full activity
Since the LTR fragment carried by pZBN was sufficient
for full activity of the R-initiator in transient transfection
analysis, we performed serial deletions of this fragment in
an attempt to find other LTR elements which may be
involved in the regulation of the initiator activity. Deletion
of the R region (pZBNDR) reproduced our previous results
(Fig. 1C, pZBNDR compared to pZBN). Furthermore, a
minimum LTR fragment carrying the HRE-4 sequence and
the respective binding sites for NF-1 and Oct-1 still ensures
the maximal activity of the R-initiator (Fig. 1C, pZSH).
Additional deletions indicate that the presence of the
binding site for the octamer-1 factor has a negative effect
(Fig. 1C, pZBX versus pZOC) on expression whereas NF-1
is an activator of the R-initiator (Fig. 1C, pZBX versus
pZNOC) which can overcome the negative effect of the two
Oct-1 binding sites.P1 deletion in the context of full-length MMTV proviruses
In view of the high luciferase expression obtained in the
reporter system using an LTR devoid of P1 promoter core
sequences, we investigated the effect on transcription of
such a deletion in the context of a complete hybrid provirus
(carried by the plasmid pGR102ES) which was shown
previously to produce infectious MMTV (Salmons et al.,
1985; Indik et al., 2005a). Three plasmids bearing full-
length MMTV recombinant proviruses with an insertion of
CMV-EGFP cassette in the 3V LTR and carrying different
deletions in the 5V LTR were constructed (Fig. 2). The first
construct, pm2DP1E (Fig. 2A), carries the 38-bp short
deletion of the P1 promoter core, thus corresponding to the
deletion in pZ1275 (Fig. 1A). The second construct,
pm2DP1DRE (Fig. 2B), carries the same deletion of the
P1 promoter core plus additional deletion of the R region
similar to that in the plasmid pZ1275DR (Fig. 1B). The third
construct, pm2BNE (Fig. 2C), carries a deletion of the first
804 bp of the 5V LTR covering the P2 promoter region, in
addition to the deletion of the P1 promoter core and thus
corresponding to the plasmid pZBN (Fig. 1A). To avoid any
read-through from either the bacterial backbone of the
plasmid or the host genome after integration, a triple
polyadenylation signal was introduced immediately
upstream of the 5V LTR sequences. An SV40 neo cassette
was cloned in antisense upstream of this polyadenylation
trimer to allow the selection of stably transfected cells.
Env is produced transiently in the absence of P1 and
requires the presence of R but not the distal part of the 5V
LTR
Dexamethasone-dependent, wild type Env expression
was detected after transient transfection of CrFK cells with
pGR102ES (Fig. 3A, lanes 2 and 3 and Fig. 3B, lanes 1 and
2). Cells transiently transfected with pm2DP1E showed the
same pattern of dexamethasone-dependent expression even
though this construct lacks the P1 promoter in the 5V LTR
(Figs. 3A and B, lanes 5 and 6). When plasmid pm2BNE
was transiently expressed in CrFK cells (Fig. 3A, lanes 7
and 8), Env production could be observed, although it was
not appreciably affected by dexamethasone treatment. This
expression pattern is similar to that observed in the
luciferase-reporter assay with pZBN (Fig. 1A). Production
of Env is strictly dependent of the presence of the R region
since the transient transfection of CrFK cells with plasmid
pm2DP1DRE did not lead to the production of Env (Fig.
3A, lanes 9 and 10).
Although a polyadenylation trimer had been inserted
between the neomycin resistance cassette and the proviral
sequence and although this had been shown to be effective
since RT-PCR failed to reveal a detectable signal from this
region (data not shown), we wanted to rule out that the
transcriptional activity we observed with pm2DP1E was due
to an effect of the SV40 enhancer. We therefore removed the
Fig. 2. Schematic presentation of MMTV recombinant proviruses. Full-length MMTV recombinant proviruses with a CMV EGFP cassette inserted in the 3V
LTR, SV40 neo cassette (gray arrow) and triple polyadenylation signal (dotted rectangle) upstream of the virus. Gray box: promoter P2; black box: promoter
P1; hatched box: R region. (A) pm2DP1E recombinant provirus carrying only the deletion of the P1 promoter core in 5VLTR. (B) pm2DP1DRE carrying the
deletion of both P1 promoter core and the R region. (C) pm2BNE carrying the deletion of the first 804 bases of 5V LTR in addition to the P1 deletion.
S. Rungaldier et al. / Virology 342 (2005) 201–214 205SV40 neo cassette from pm2DP1E to obtain the plasmid
pm2DP1EDn. No differences in Env production could be
observed after transient transfection of CrFK cells with
either pm2DP1E or pm2DP1EDn (Fig. 3B, lanes 5 and 6
compared to lanes 7 and 8). Thus, the presence of the SV40
neo cassette in antisense direction in these recombinant
provirus containing plasmids is not responsible for theFig. 3. MMTV Env Western blot of total proteins from cells stably or transiently t
protein extract was separated by SDS PAGE, blotted, and Env detected using a p
seen in all lanes. Lanes with a ‘‘+’’symbol indicate the samples where cells receive
CrFK cells. Non-transfected CrFK cells (lane 1), CrFK transfected with: pGR102
pm2DP1DRE (lanes 9 and 10), marker (lane 4). (B) Transient transfections of
pGR102ES (lanes 1 and 2), pm2DP1E (lanes 5 and 6), pm2DP1EDn (lanes 7 and 8
P1-deleted recombinant provirus containing clones (CDP1AnE) express Env. GR
CrFK clones transfected with pm2 DP1E: CDP1AnE 11 (lanes 5 and 6), CDP1AnE
provirus containing clones (CDP1DRAnE ) do not express Env. Non-transfected
control: CDP1AnE 11 (lanes 2 and 3), marker (lane 4), stable CrFK clones transfe
(lanes 7 and 8), CDP1DRAnE 28 (lanes 9 and 10). (E) Stable transfections: clones
the 5V LTR (CBNAnE) do not express Env. CDP1AnE (lanes 1 and 2), non-trans
pmtv2BNpAneoEs: CBNAnE 6 (lanes 5 and 6), CBNAnE 7 (lanes 7 and 8), CBobserved transcriptional activity in the absence of the P1
promoter.
On the other hand, removal of the complete 5V LTR
(pdGRESDLTR) completely abrogates expression of Env
after transient transfection of CrFK cells (Fig. 3B, lanes 9
and 10), confirming that the element controlling env gene
expression is located within the 5V LTR.ransfected with wild type or deletion mutant proviruses: 20 Ag of each total
olyclonal anti-Env antibody. A nonspecific protein of about 50 kDa can be
d dexamethasone 8 h prior protein extraction. (A) Transient transfection of
ES (lanes 2 and 3), pm2DP1E (lanes 5 and 6), pm2BNE (lanes 7 and 8),
CrFK cells. Non-transfected CrFK cells (lane 3), CrFK transfected with:
), pdGRESDLTR (lanes 9 and 10), marker (lane 4). (C) Stable transfections:
cells (lanes 1 and 2), non-transfected CrFK (lane 3), marker (lane 4), stable
12 (lanes 7 and 8). (D) Stable transfections: P1- and R-deleted recombinant
CrFK (lane 1), stable CrFK clones transfected with pm2 DP1E as positive
cted with pm2DP1DRE: CDP1DRAnE 10 (lanes 5 and 6), CDP1DRAnE 20
carrying recombinant proviruses with deletions in P1 and the first 804 bp of
fected CrFK (lane 3), marker (lane 4), stable CrFK clones transfected with
NAnE 16 (lanes 9 and 10).
Fig. 4. RACE of 5V end of the env message: (A) 3 different reverse primers in env were used for the 5V RACE: 7933 for reverse transcription, 7831 for the
1st PCR after polyadenylation of the 5V end of the RNA with oligo dT anchor primer, 7803 for the 2nd PCR with anchor primer. (B) The 1600-bp band
resulting from the second PCR was extracted from the gel and cloned into a TOPO vector. (C) Different TOPO clones were analyzed by sequencing. DP1
indicates the site of the P1 promoter core deletion. The R region, SA in U5, SD and start of gag are highlighted. The arrows indicate the detected 5V ends of the
mRNAs, with the bold arrows indicating a start site in at least 2 different clones.
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Env expression in the absence of the P1 promoter in stably
transfected cells
Dexamethasone-inducible Env protein production could
be detected in a number of independent CrFK cell clones
(CDP1AnE) that had been shown by Southern blotting (not
shown) to have stably acquired the transfected plasmid,
pm2DP1E, in which only the P1 promoter has been deleted.
The amount of gp 52 produced is significantly higher whenFig. 5. Primer extension for the detection of P1 directed transcription initiation in
from CrFK cells (lane 1), GR cells + dex (lane 2), CDP1AnE11 + dex (lane 3), an
pGR102ES was submitted to primer extension with end-labeled oligo P1.CGRES
dexamethasone (lane 7), and marker (lane 8).two representative clones CDP1AnE11 (Fig. 3C, lanes 5 and
6) and CDP1AnE12 (Fig. 3C, lanes 7 and 8) were treated with
dexamethasone (Fig. 3C, lanes 6 and 8 compared to lanes 5
and 7). As expected, no MMTV Env production could be
detected in protein extracts from parental CrFK cells (Fig. 3C
lane 3) while dexamethasone-inducible Env production was
observed in GR mammary tumor cells (Fig. 3C, lane 2
compared to lane 1). Also, in keeping with the results
observed using the luciferase reporter system (Fig. 1B), no
Env production was detectable in CDP1DRAnE clonesMMTV expressing cells. (A) Primer PEP1was hybridized with total RNA
d marker (lane 4). (B) Total RNAs from stable CrFK clone transfected with
1 + dexamethasone (lane 5), CGRES 1-dexamethasone (lane 6), CGRES 6-
S. Rungaldier et al. / Virology 342 (2005) 201–214 207carrying the deletion of both the P1 promoter and the R
region, (Fig. 3D, lanes 5 to 10). However, in contrast to the
data obtained upon transient transfection, we could not detect
Env production in all of the 14 stable CBNAnE clones we
analyzed carrying a deletion of the first 804 bp of the 5V LTR
in addition to the P1 deletion. Western blotting analyses of
three of these clones are shown in Fig. 3E, lanes 5 to 10.
Thus, taken together, using two different experimental
approaches (the luciferase reporter system and Env expres-
sion in the viral genomic context), the deletion of a short
sequence encompassing the P1 promoter core does not result
in the loss of gene expression but rather results in an
upregulation of gene expression. This expression is only
dependent on the presence of the first 804 bp of the LTR in
stably integrated clones and not in transiently in transfected
cells.
A hotspot for RNA initiation is located immediately 3V of the
R-initiator
To detect the origin of the transcript encoding the env
message in clone CDP1AnE11, mRNA was extracted from
dexamethasone-stimulated cells and 5V RACE performed.
For the reverse transcription step, we used a specific primer
in env (7933, location in viral genome is indicated in Fig.
4A). Subsequently, a PCR and a semi-nested PCR were
performed with internal env-specific reverse primers (Fig.
4A). The 1600-bp band (Fig. 4B) resulting from the semi-
nested PCR was then cloned into a plasmid and independent
bacterial colonies were analyzed by sequencing for the
region of interest. Different transcription initiation sites
which could be detected in the 5VLTR as indicated by arrowsFig. 6. FACS analysis of infected CrFK (A) and NIH3T3 (B) cells. Infection essa
CDP1AnE11 cell clones. CGRES6 or CDP1AnE11 were stimulated overnight b
producer cell clone obtained by transfection of CrFK cells with pGR102ES where
the P1-deleted mutant pm2DP1E. Infected cells were subjected to FACS analysis 4
from P1-deleted clone was used for assay.in Fig. 4C show that while no unique, invariant start of
transcription from the R-initiator could be detected, a hotspot
of initiation occurs immediately downstream of the initiator
sequence previously described by others (Pierce et al., 1993).
P1 is functionally absent in clone CDP1AnE11
Total RNA isolated from dexamethasone-stimulated
CDP1AnE11 cells as well as from dexamethasone-stimulated
GR and CrFK cells were used for primer extension with
primer PEP1, a 24-mer oligonucleotide which hybridizes 50
nucleotides downstream of the transcription initiation site of
P1. The P1 initiation site could be only detected in GR cells
stimulated by dexamethasone (Fig. 5A, lane 2, indicated by
an arrow) but not in P1-deleted CDP1AnE11 cell clone. We
could not detect the start of transcription of the env message
by primer extension possibly due to the multiple initiation
sites downstream of the R-initiator described above. In
another primer extension assay, we could also demonstrate
the start of P1 with total RNA isolated from the stable clones
CGRES1 and CGRES6, transfected with pGR102ES, using
oligo P1 (Fig. 5B, lane 5), indicating that the insertion of
EGFP into the 3V LTR does not affect transcription initiation
at P1 in the 5V LTR. Furthermore, we could detect the
dexamethasone-dependent stimulation of promoter P1 (Fig.
5B, compare lanes 5 and 6).
P1-deleted MMTV is not infectious
To investigate whether the P1-deleted clone CDP1AnE11
is able to produce infectious viral particles, infection assays
of CrFK and NIH3T3 cells were performed with concen-ys were performed with filtered supernatants (SN) from stable CGRES6 or
y dexamethasone before supernatant was harvested. CGRES 6 is a stable
as CDP1AnE11 has been obtained by stable transfection of CrFK cells with
8 h after infection. Infection events could not be detected when supernatant
S. Rungaldier et al. / Virology 342 (2005) 201–214208trated supernatant and 48 h later the infection efficiency was
determined by FACS analysis. Positive infection events
were obtained with the supernatant from the MMTV
producer CGRES6 clone; however, no infection events
could be detected when supernatant from CDP1AnE11 was
used (Fig. 6).
Little full-length RNA is detected from a P1-deleted MMTV
recombinant provirus
Because no infection was obtained with supernatant from
CDP1AnE11 even though this clone expresses large quan-
tities of Env (Fig. 3C, lane 6), we determined whether
genomic length viral RNA can be produced. RT-PCR
analysis revealed a product indicative of a genomic length
transcript only when the provirus carried an intact P1
promoter such as in GR cells (Fig. 7, panel A, lane 1) but
not from recombinant proviruses carrying a deletion in P1
such as clone CDP1AnE11 (Fig. 7, panel A, lane 3). Further
examination by Northern blotting revealed only very weak
expression of full-length RNA in the CDP1AnE11 clone
after hybridization with an env (Fig. 7, panel B, lane 2) orFig. 7. Full-length viral RNA detection. (A) By RT PCR: Total RNAs from dex
treated with DNaseI prior to reverse transcription (RT) using oligo dT primers. A s
primer pair used in the subsequent PCR step as well as an agarose gel of the RT-PC
GR (lane 2), cDNA CDP1AnE11 (lane 3), RNAs prior to RT step CDP1AnE 11(lan
(lane 6), 1 kb marker (lane 7). DNA contamination of the cDNAs can be ruled ou
were used to prepare the corresponding cDNAs. (B) By Northern blotting: mRN
Northern analysis and hybridized to either an env (lanes 1 and 2) or gag (lane 3 a
deleted recombinant provirus (lanes 1 and 3), or 3 Ag of mRNA from clone CDP1
P1 promoter core (lanes 2 and 4) is shown.gag (Fig. 7, panel B, lane 4) probe and only when three
times more mRNA was loaded in comparison to the non-
deleted recombinant provirus (Fig. 7, panel B, lanes 1 and
3). These data indicate that the R Inr cannot substitute for
the absence of the P1 promoter to produce amounts of full-
length genomic viral RNA comparable to that observed in
the presence of P1. The absence of infection events when
supernatant from the P1-deleted clone CDP1AnE11 was
used for infection assays (Fig. 6) supports this conclusion.
Since we could observe env mRNA and protein production
but no or little full-length viral RNA in the absence of P1,
the question arises whether MMTV env mRNA is indeed an
exclusively subgenomic product of the full-length viral
RNA. Either the env message is not a spliced product of the
full-length viral template RNA, or alternatively, the full-
length viral RNA produced by the initiator in the absence of
P1 is extremely unstable or is immediately and almost
completely spliced.
The presence of an initiator (Inr)-like element in the
MMTV R region, from +4 to +10 relative to the start of
transcription of the P1 promoter, has already been reported
(Pierce et al., 1993). Additionally, the same group identifiedamethasone-stimulated CDP1AnE11 cells and GR cells were isolated and
chematic representation of the proviral sequence showing the location of the
R products is shown. cDNA from GR (lane 1), RNAs prior to RT step from
e 4), positive control: pmtv2DP1pAneoEs (lane 5), negative control of PCR
t since no amplification was obtained using both RNA samples before they
A was prepared from cells treated with dexamethasone and subjected to
nd 4) specific probe. 1 Ag of mRNA from clone C2AnE15, carrying a non-
AnE 11 carrying the same recombinant provirus except for a deletion of the
S. Rungaldier et al. / Virology 342 (2005) 201–214 209a protein which specifically recognizes this region, the
initiation site binding protein (ISBP). However, they were
not able to detect any transcripts from MMTV promoters
with TATA box mutations and concluded that the ISBP site
does not direct specific initiation in the absence of a TATA
box but only plays a role in start site selection for the
MMTV P1 promoter. For this reason, in addition to the fact
that the element is situated downstream of the start of
transcription, these authors propose that the function of the
MMTV Inr is not analogous to that of a classic initiator
element (Fee et al., 2002). However, our results show that
the Inr contained within the MMTV R region controls
transcription initiation in the absence of P1, and is sufficient
to drive transcription of the structural Env mRNA. The start
of transcription was mapped in CDP1AnE 11, a clone with a
deletion of the P1 TATA box in the 5V LTR that produces
large amounts of Env protein and revealed a hotspot for
heterogeneous transcription initiation just 3V of the region
(Fig. 4). Such variability in the start of transcription is
common to Inr elements working independently of TATA
boxes, supposedly because RNA polymerase II has only one
anchorage point and the resulting transcription complex can
therefore slide. It is thought that if both TATA and Inr motifs
are present, complexes formed on either of them can co-
operate and therefore precisely fix the transcriptional start
site (Carcamo et al., 1991; Weis and Reinberg, 1992;
Javahery et al., 1994; Smale and Baltimore, 1989).
Pierce et al. (1993) most probably were not able to detect
the start of transcription from the initiator in the absence of
P1 since the method they employed, primer extension, will
only give an unambiguously interpretable signal if the
majority of the RNA initiates at one specific site. 5V RACE
on the other hand allows the characterization of each initiated
message. Indeed, we also were not able to detect the
transcriptional start site from the Inr element in the R region
using primer extension, but only after cloning and sequenc-
ing individual messages during the 5V RACE procedure.
The env transcript initiated from the R Inr independently
of the P1 promoter (Fig. 4) exhibits the same splicing
pattern as previously reported (Majors and Varmus, 1983).
Furthermore, the dexamethasone regulation of Env produc-
tion and its maturation (Fig. 3C, lanes 5 to 8) are identical to
that in GR cells (Fig. 3C, lanes 1 and 2), derived from an
MMTV-induced mouse mammary tumor, and NMuMG
MMTV-producing cells (Redmond and Dickson, 1983;
Henderson et al., 1983; Goodman and Firestone, 1993).
The recombinant provirus pm2BNE carries a deletion in
both P1 and in the 5V distal part of the LTR up to the HRE.
Interestingly, whereas pm2BNE showed no Env expression
in the stably transfected clones (Fig. 3E, lanes 5 to 10), Env
was produced when the construct was transiently trans-
fected, but the Env level does not increase significantly after
stimulation of transiently transfected cells with dexametha-
sone (Fig. 3A, lanes 7 and 8). Only constructs carrying the
full MMTV LTR (pm2DP1E) showed hormone-regulated
Env expression in the absence of P1 after stable transfection(Fig. 3C, lanes 5 to 8). This may indicate a difference in
regulation of the R Inr according to the integration status of
the LTR sequence into the host genome. Whereas the distal
part of the LTR U3 is not required for full activity of the R
Inr transiently, it is necessary for protein expression in
stably transfected cells. The distal part of the MMTV LTR
has been reported to harbor an enhancer region that affects
the overall LTR transcriptional activity (Mink et al., 1990;
Gouilleux et al., 1991; Lefebvre et al., 1991). However, the
results presented here are in apparent contradiction with
previous reports by Peterson and collaborators (Toohey et
al., 1990; Pierce et al., 1993). Using a reporter system in
which CAT expression was placed under the control of
MMTV LTR fragments spanning from 831 to 1326 (363
to +133 relative to the start of transcription), these authors
analyzed the effect of the mutations on both basal and
hormone-induced transcription. The major discrepancy
between our results and the results published by these
authors concerns the importance of the TATA box in the
overall transcriptional activity of the MMTV LTR. Even
taking into account only the most similar fragments in both
systems (LTR 831 to 1326 for these authors, LTR 795 to
1302 for us), a mutation of the TATA box leads to a 6- to 8-
fold reduction of both basal and hormone-induced tran-
scription in their system (Toohey et al., 1990), whereas a
deletion of the TATA box in our system leads to a basal level
of transcription similar in magnitude to the normal
hormone-stimulated transcription and an even higher level
of expression in the presence of dexamethasone (Fig. 1). At
present, we have no simple explanation for this discrepancy.
Nuclear factor 1 (NF-1) is required for full activity of R
Inr, but is not essential since in the absence of an NF-1
binding site, expression is reduced twofold (Fig. 1C).
During transient transfection, the MMTV promoter is not
organized in the same chromatin structure as the integrated
proviral promoter. The NF-1 binding site, which is part of
nucleosome B in the integrated provirus in the absence of
hormone, is normally occluded and thus cannot bind NF-1
(Archer et al., 1992). Hebbar and Archer have reported a
transactivation of basal transcription by NF-1 binding in the
absence of organized chromatin (Hebbar and Archer, 2003),
while others limit the role of NF-1 to chromatin remodeling
(Di Croce et al., 1999; Vicent et al., 2002) which is a
necessary step for maximal P1 promoter activity. That the
NF-1 binding site is not essential for progesterone mediated
in vitro stimulation of MMTV transcription has also been
shown by Kalff and co-workers (Kalff et al., 1990). One
possible explanation for these findings is that these authors
may be observing two different phenomena, namely, on the
one hand, a structural role of NF-1 for the activity of the P1
promoter in the integrated proviral state, and on the other,
the dependency of Inr on NF-1 in the absence of chromatin.
In conclusion, we report here dexamethasone-regulated
production of Env protein in the absence of the P1 LTR core
promoter. This expression is dependent of the R-initiator,
previously described by Pierce et al. (1993) which however
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of the genomic viral RNA. Almost no full-length RNA is
detectable in the absence of P1 but nevertheless Env is
produced. Thus, there is no correlation between the amount
of full-length RNA available and the amount of spliced env
mRNA. Furthermore, the distal part of the 5V LTR U3 seems
to be essential for full activity of the initiator in the presence
of organized chromatin but is not required for transient
expression.
When the P1 promoter is functional, the start of
transcription driven by this promoter is well defined and
located at the first nucleotide of the R region. This site is
upstream of the transcriptional starts of the initiator which
map in a hotspot immediately downstream of the R Inr
sequence. We propose that the first nucleotides of R, that are
present on the full-length viral RNA, but not on the env
mRNA we describe here, are necessary to protect the viral
RNA from being transported to the spliceosomes. Previous
to this study, it was believed that all MMTV transcripts
driven by the LTR P1 promoter initiate at the first base of
the R region. It is extremely difficult to differentiate
genomic viral RNA from subgenomic env mRNA while
studying their respective 5V end by reverse transcription.
Here, full-length viral RNA is virtually absent; thus,
interference of this molecule is minimal, allowing us to
observe this discrete product.
We propose that there are 2 different families of
transcripts originating from the proximal part of the MMTV
5V LTR. The P1 promoter is strictly dexamethasone depend-
ent for its activity and transcription is initiated at position
1194 (relative to position 1 at the first base of the U3, in the
5V LTR of the proviral sequence), at the first base of the R
region of the provirus. This full-length message is exported
without being spliced, escaping processing likely due to the
interaction with a factor that remains to be identified. A
candidate for this factor could be the newly discovered
virally encoded export protein Rem (Indik et al., 2005b).
The start of transcription from the R-initiator is not precise
and the RNAs produced are either highly instable, or
alternatively, immediately transferred to the splicing machi-
nery, where a single intron is removed. In this model, the
env mRNA is not a subgenomic product of the viral
genomic RNA, but rather a discrete, independently regu-
lated message. In this model, the increased production of
MMTV Env protein in the presence of dexamethasone
would be due to both transcriptional and posttranscriptional
regulation as previously proposed (Firestone et al., 1982;
Amacher et al., 1989; Goodman and Firestone, 1993).Materials and methods
Reporter system analysis
The plasmid pdGR102 (Salmons et al., 1985) was
digested with ClaI and self-ligated leading to pdGR102Cla,carrying only one LTR of Mtv-2 origin. pZ1303 was
obtained by ligation of the promoterless expression plasmid
pZluc (Brasier et al., 1989; Maxwell et al., 1989) digested
with HindIII and BamHI with the HindIII and BamHI gel
purified PCR fragment which was obtained from pdG-
R102Cla using primers Z1 (5V-AAAGGATCCGCGCCTG-
CAGCAGAA) and Hindrev (5V-GAGGAAGCTTGACCQ
GGGATCTGCGG). To construct pZ1316, we first modified
pdGR102Cla by directed mutagenesis, inserting 5 base pairs
(bp) immediately upstream of the R region, creating a
unique XhoI site in the resulting plasmid, pdGR102Xho.
pZ1316 was then obtained following the same strategy as
for pZ1303 but using pdGR102Xho as template instead of
pdGR102Cla. The only difference between pZ1303 and
pZ1316 is a 5-bp insertion immediately upstream of the R
region. pdGR102Xho was digested with SacI and XhoI and
a fragment carrying the P1 promoter deletion was intro-
duced in place of the wild type sequence, leading to
pdGR102DP1. The P1-deleted fragment was obtained by
annealing the complementary oligonucleotides 1DELP1 (5V-
CTTAGTGTTCTATTTTCCTATGTTCTTTTGGAAT-
CTATCCAAGTCTTATGTAAATGCTTATGTAAAT) and
2DELP1 (5V-TCGAGTTTACATAAGCATTTACATAA-
GACTTGGATAGATTCCAAAAGAACATAGGAAAATA-
GAACACTAAGAGCT) thus creating SacI and XhoI sticky
ends. pZ1275 was then obtained following the same strategy
as for pZ1303 but pdGR102DP1 was used as template
instead of pdGR102Cla. A PCR fragment was obtained
using pZ1275 as template and primers delB (5V-AAAG-
GATCCTAACTGAGAAAGACGACATG) and Hindrev,
gel purified, digested and inserted into pZluc digested with
BamHI and HindIII to create pZBN which is lacking the first
804 bp of the LTR. pZBX was obtained by digestion of
pZBN with BamHI and XhoI, subsequently treated with
DNA polymerase before a self-ligation step. Gel purified
PCR fragment was prepared using pdGR102Cla as template
and primers BX1208 (5V-AAAGCGGATCCCGACCCTC-
GAGCATTCTTCTCTCGTGTGTTTG) and Hindrev. After
digestion with XhoI and HindIII, it was inserted on the one
hand into vector pZBN digested with XhoI and HindIII
leading to pZBNDR and on the other hand into vector
pZ1275 digested with the same enzymes leading to
pZ1275DR. All of the fragments obtained by PCR were
sequenced in the resulting plasmids to check the integrity of
the sequences of interest and only clones carrying LTR
sequences fully identical to original Mtv-2 sequence were
used further. In addition, two independent clones were
grown for plasmid preparation and independently tested in
transfection. Transfection experiments were performed
using 2 Ag of DNA for 4  105 cells in 6-well plates,
each point in duplicate. Transfection efficiencies were
determined by co-transfecting 0.5 Ag of pEGFPc1 in
parallel with the plasmid of interest with and by submitting
the cells to FACS analysis for EGFP 48 h after transfection.
Experiments were repeated at least 3 times. Cells were
rinsed twice after 8 h after transfection and then incubated
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sone induction was tested, transfected cell medium was
removed 10 h before protein extraction and exchanged with
the same cell culture medium containing 106 M dexame-
thasone. Luciferase assays were performed 48 h after
transfection. After lysis of the transfected cells, protein
extracts were kept on ice and assayed (Bio-Rad) immedi-
ately for total protein concentration measurement at 630 nm
using an Elx800 (Bio-Tech Instruments). 20 Ag of protein
from each sample was used per point for luciferase assays
using an Autolumat LB 953 (Berthold).
Proviral constructs
The plasmid pGR102 was restriction digested with AflII
and NcoI, sticky ends filled up with T4 DNA polymerase
and self-ligated in order to obtain pdGR5V LTR carrying
only the bacterial backbone, the mouse sequence flanking
the 5V LTR, the Mtv-8 5V LTR, and the first half of gag from
the provirus. Vector pdGR5V LTR was linearized by HindIII
and BstEII, removing the mouse sequence and the 5VMtv-8
LTR and ligated in one step to two independent PCR
fragments. The first one is an amplification of the SV40 neo
expression cassette from pcDNA3 (Invitrogen) with 2
primers carrying at their ends HindIII and SpeI, respec-
tively. The second one is an amplification of the poly-
adenylation trimer and the Mtv-2 LTR deleted for P1
obtained by PCR of pZ1275 with primers SpsapA (5V-
AAAACTAGTCAGGTCGACTCTAG AGGATCTGG-
CACTC) and BMtv2LTRe (5V-AAGGTCACCGGGA-
TCTGCGGGG), ending with SpeI and BstEII restriction
sites, respectively. After restriction digestion of the two PCR
fragments with the corresponding restriction enzymes, they
were both introduced into pdGR5VLTR linearized byHindIII
and BstEII, leading to pdLTRDP1pAneo. pdLTRDP1pAneo
was then digested with BsAI and the 7150-bp-long gel
purified fragment was used for homologous recombination
(Bubeck et al., 1993; Chartier et al., 1996) in bacterial strain
JC5176 (Capaldo-Kimball and Barbour, 1971) with the
vector pGR102ES linearized with PvuII and dephosphory-
lated. The resulting plasmid pm2DP1E carries an EGFP-
MMTV recombinant provirus with the same short P1
promoter core deletion in its 5V LTR as in pZ1275, a
polyadenylation trimer just upstream of the proviral
sequence and an expression cassette for neomycin resistance
in antisense (Fig. 4). The plasmid pm2DP1DRE was
constructed in two steps. In the first step PCR, a fragment
was produced using pZ1275DR as template and primers
SpsapA and BMtv2LTRe, digested with SpeI and BstEII,
gel purified and ligated to dephosphorylated vector
pmtv2LTRDP1neo previously digested with SpeI and
BstEII, leading to pLTRDP1DRpAneo. pLTRDP1DRpAneo
DRpAneo was digested with BsAI. The 7139-bp-long
fragment was gel purified and submitted to homologous
recombination with pGR102ES which was previously
digested with PvuII and dephosphorylated. The resultingplasmid was named pm2DP1DRE. The same strategy as
above was adopted to produce pm2BNE but PCR amplifi-
cation was performed using pZBN as template instead of
pZ1275DR, resulting in the transfer plasmid pLTRBNpA-
neo for the subsequent homologous recombination step.
The pm2DP1EDn plasmid was obtained by SalI restriction
of pm2DP1E and self-ligation, leading to the removal of
the SV40-neomycin expression cassette. The plasmid
pdGRESDLTR was obtained by PshAI restriction of
pGR102ES and self-ligation leading to the removal of all
the mouse and 5V LTR sequences.
Cell culture
CrFK (Crandell et al., 1973) and GR mouse mammary
carcinoma cells, productively infected with MMTV (Ring-
old et al., 1975), were maintained in DMEM with Glutamax
(Invitrogen) containing 10% heat inactivated fetal bovine
serum. Whenever needed, cultivated cells were stimulated
with 1 AM dexamethasone for 8 to 16 h.
Transfection
All transfections were performed using the calcium
phosphate coprecipitation method: 24 h prior to the trans-
fection, 1.5  106 cells were seeded in 10-cm cell culture
dishes. The cells were transfected with 20 Ag of plasmid
DNA, and after incubation at 37 -C for 8 h, medium was
removed and the cells were washed with PBS and supplied
with fresh medium. After another 48 h, some dish
containing transfected cells were stimulated with dexame-
thasone (see above) and then harvested as transiently
transfected cells. Stably transfected cell clones were selected
with 400 Ag/ml of G418.
Selection of stable clones
Prior to stable transfection into CrFK cells, each plasmid
was digested with NruI and PvuI in the bacterial backbone
leaving only the region of interest as well as the SV40 neo
cassette, triple polyadenylation signal, and the full hybrid
EGFP-MMTV proviral sequences. Selection of single cell
clones was based on both resistance to G418 and EGFP
expression, thus assuring the integrity of the region of
interest. Cell clones derived from pm2DP1E were called
CDP1AnE, those derived from pm2DP1DRE were called
CDP1DRanE, and clones from pm2BNE were called
CBNAnE. The clones were analyzed for acquisition of
proviral DNA by PCR followed by sequencing of the PCR
products and Southern blot.
Infection
24 h prior to the infection, 2  105 recipient cells/6-well
were seeded and producer cells were stimulated with 1 AM
dexamethasone overnight before infection. Supernatant of
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concentrated by ultracentrifugation for 2 h at 4 -C at
83,000  g. Polybrene (SIGMA) was added to cells at 8 ng/
ml together with 2 ml of supernatant. Cells were incubated
at 37 -C for 6 h before adding 2 ml of fresh medium.
Medium was changed after 24 h, and 48 h after infection,
the cells were analyzed by FACS (Becton Dickinson: FACS
Calibur).
Western blot analysis
Protein extraction from stable clones: Cell pellets were
weighed and resuspended in 200 Al PBS. Before the cells
were destroyed by ultrasonication, proteinase inhibitor
(SIGMA) was added to the cells at 0.5 Al/0.01 g of wet
pellet weight. The amount of protein was measured using
the DC Protein Assay Kit (Bio-Rad) and the absorbance read
at 690 nm (Bio-Tek ELX 800). Protein extraction from
transiently transfected cells: medium was removed 48 h
after transfection, the plate was placed on ice and the cells
were washed twice with ice-cold PBS (phosphate buffered
saline). 100 Al of the protein sample buffer (100 mM Tris–
HCl pH 6.8, 5% SDS, 20% glycerol, 0.02% bromphenol
blue, 10% h-mercaptoethanol) was added and the cells were
harvested by scraping followed by ultrasonication. Protein
amount was estimated after performing SDS-PAGE and
staining the gel using Coomassie. Protein lysates were
subjected to SDS-PAGE, transferred to HybondP PVDF
transfer membrane (Amersham) and after blocking over-
night in 5% milk powder-TBS/Tween, probed with a
polyclonal MMTV gp52 positive rabbit serum. Anti-rabbit
IgG, HRP-linked whole AB, donkey (Amersham) was used
as secondary antibody. Protein detection was performed
using the ECL Plus Western blotting detection reagents
(Amersham). Gels were subjected to autoradiography using
Hyperfilm (Amersham) for 5 to 15 min.
RNA extraction
Total RNA was extracted from cell pellets of 106–107
cells/pellet using the RNeasy Mini Kit (QIAGEN) and
mRNA was extracted using the QuickPrep micro mRNA
Purification Kit (Amersham) following the protocol sup-
plied by the manufacturer. To prevent any possible DNA
contamination, total RNAwas treated with RQ1 RNase free
DNaseI from Promega also following the manufacturer’s
protocol. Total RNA and mRNA were stored at 80 -C for
further analysis.
5V RACE
To analyze the start of transcription of mRNAs, the 5V/3V
RACE kit from Roche was used and the method was
performed as suggested by the manufacturer. 1.2 Ag of
mRNA extracted from the clone CDP1AnE11 was used for
reverse transcription with oligo 7933 (5V-AGCGAC-GAATCGCTTAGCTCGAA-3V). A purification kit (Roche)
was used for the purification of cDNA according to the
manufacturer’s protocol. The purified and 5V poly A tailed
cDNA was used in the first PCR amplification with the
specific reverse primer 7831 (5V-CACGTATGGCGG-
CCTCTTGACTA-3V) and the oligo dT-anchor primer
(provided with the kit). 1 Al of the first PCR product was
the template for the next PCR using a nested specific primer
7803 (5V-GCTGCATAGTCGTAGGCAGAAGA-3V) and
the anchor primer (provided with the kit). The amplification
product was analyzed by cloning into a TOPO-vector
(TOPO XL PCR Cloning kit, Invitrogen) and the clones
containing the right-sized insert were sequenced.
Primer extension
The primer extension assay on total RNA extracts
obtained from CrFK and GR (stimulated with dexametha-
sone) cells, CGRES 1 (both stimulated and not with
dexamethasone) and 6 (not stimulated with dexamethasone),
and CDP1AnE 11 (stimulated with dexamethasone) was
performed using the Primer extension system-AMV reverse
transcriptase (Promega). 50 Ag of total RNA was either
annealed with the [g-32P]ATP end-labeled PEP1 (5V-
AAGGATAAGTGACGAGCGGAGACG-3V) or oligo P1
and subsequently reverse transcription was performed.
Products were fractionated on an 8% polyacrylamide gel
containing 0.1 M Urea and the dried gel was exposed to a
Phosphorimager screen (Fujifilm).
RT-PCR
1 Ag of total RNA (DNase treated) was reverse tran-
scribed with oligo dT primer using SuperScript II Reverse
Transcriptase (Invitrogen) following the manufacturer’s
protocol. PCR was performed using Taq DNA polymerase
(QIAGEN). Primers for detection of part of the full-length
viral RNA were +1425 (5V-CACAAGAGCGGAACG-
GACTCAC-3V) and 4547 (5V-CCACTGGAATCTTTGA-
TAGGGTCTC-3V). 5 Al of the RT-reaction of the samples or
50 ng of plasmid DNA (pm2DP1E) was used as PCR
template. The resulting PCR products were visualized by
electrophoresis on a 0.9% agarose gel.
Northern blot analysis
mRNAwas extracted from the CDP1AnE 11 and C2AnE
15 cell clones using QuickPrep micro mRNA purification
kit (Roche) and following the manufacturer’s protocol.
Electrophoresis was performed with 1 Ag of mRNA from
clone C2AnE 15 and 3 Ag of mRNA derived from clone
CDP1AnE 11 on a denaturating formaldehyde agarose gel.
Blotting onto a hybond N+ membrane (Amersham) was
performed via wet, upward capillary transport. The blot was
prehybridized with rapid-hyb buffer (Amersham) and
hybridized with either an env-probe (Apa I fragment of
S. Rungaldier et al. / Virology 342 (2005) 201–214 213pGR120ES) or a gag probe (Ava I fragment of pGR120ES)
labeled with P32a-dCTP. The blot was visualized by
exposure on an X-ray film (Amersham).Acknowledgments
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